Jack Syage
Präsident bei ENTERO THERAPEUTICS, INC.
Vermögen: 42 042 $ am 30.04.2024
Profil
Jack A.
Syage was the founder of Syagen Technology, Inc. (founded in 1996) where he held the title of Chairman, President & CEO from 2009 to 2011.
He was also the founder of ImmunogenX, Inc. (founded in 2013) where he served as the Chief Executive Officer & Director until 2024.
Currently, Dr. Syage holds positions at Advanced Telesensors, Inc. as a Director, at First Wave Biopharma, Inc. as the President, Chief Operating Officer & Director since 2024, and at PhageTech, Inc. as a Director.
In terms of education, Dr. Syage obtained a doctorate degree from Brown University in 1982 and an undergraduate degree from Hamilton College (New York) in 1976.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 13.03.2024 | 15 400 ( 0,76% ) | 42 042 $ | 30.04.2024 |
Aktive Positionen von Jack Syage
| Unternehmen | Position | Beginn |
|---|---|---|
| ENTERO THERAPEUTICS, INC. | Präsident | 13.03.2024 |
Advanced Telesensors, Inc.
 Advanced Telesensors, Inc. Packaged SoftwareTechnology Services Advanced Telesensors, Inc. develops heart rate sensor which auto-captures heart and respiratory rates at a distance. It offers Sleep Tyte, a video monitoring system for parents to view their baby’s physical condition via smartphones. The company was founded by Paolo Focardi in 2009 and is headquartered in Pasadena, CA. | Direktor/Vorstandsmitglied | - |
PhageTech, Inc.
 PhageTech, Inc. Miscellaneous Commercial ServicesCommercial Services PhageTech, Inc. provides medical services. The firm develops bacteriophage sensors related tests for detecting analytes in urine, blood, and other body fluids. Its technology is used for advanced diagnostics, such as early stage cancer detection, drug dosage monitoring, and time sensitive diseases and conditions. The company was founded by Richard W. Henson, Gregory Weiss, and Reginald Penner in 2014 and is headquartered in Irvine, CA. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Jack Syage
| Unternehmen | Position | Ende |
|---|---|---|
ImmunogenX LLC
 ImmunogenX LLC BiotechnologyHealth Technology ImmunogenX LLC develops diagnosis and treatment for autoimmune and gastrointestinal diseases. It focuses on therapy, disease management, and food safety. The company was founded by Jack A. Syage and Jennifer A. Sealey-Voyksner in 2013 and is headquartered in Newport Beach, CA. | Gründer | 13.03.2024 |
Syagen Technology, Inc.
 Syagen Technology, Inc. Medical SpecialtiesHealth Technology Syagen Technology, Inc. develops mass spectrometry products and technology for molecular analysis. It offers atmospheric pressure photo ionization (APPI) ion sources that are used for the ionization of a range of compounds, including non-polar compounds; ion sources with APCI/APPI combination that are used for the ionization of non-polar compounds; and APCI/APPI probes that are used for introducing samples into the ion source. The company was founded by Jack A. Syage in 1996 and is headquartered in Tustin, CA. | Vorstandsvorsitzender | - |
Ausbildung von Jack Syage
| Brown University | Doctorate Degree |
| Hamilton College (New York) | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ENTERO THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Syagen Technology, Inc.
Syagen Technology, Inc. Medical SpecialtiesHealth Technology Syagen Technology, Inc. develops mass spectrometry products and technology for molecular analysis. It offers atmospheric pressure photo ionization (APPI) ion sources that are used for the ionization of a range of compounds, including non-polar compounds; ion sources with APCI/APPI combination that are used for the ionization of non-polar compounds; and APCI/APPI probes that are used for introducing samples into the ion source. The company was founded by Jack A. Syage in 1996 and is headquartered in Tustin, CA. | Health Technology |
PhageTech, Inc.
PhageTech, Inc. Miscellaneous Commercial ServicesCommercial Services PhageTech, Inc. provides medical services. The firm develops bacteriophage sensors related tests for detecting analytes in urine, blood, and other body fluids. Its technology is used for advanced diagnostics, such as early stage cancer detection, drug dosage monitoring, and time sensitive diseases and conditions. The company was founded by Richard W. Henson, Gregory Weiss, and Reginald Penner in 2014 and is headquartered in Irvine, CA. | Commercial Services |
ImmunogenX LLC
ImmunogenX LLC BiotechnologyHealth Technology ImmunogenX LLC develops diagnosis and treatment for autoimmune and gastrointestinal diseases. It focuses on therapy, disease management, and food safety. The company was founded by Jack A. Syage and Jennifer A. Sealey-Voyksner in 2013 and is headquartered in Newport Beach, CA. | Health Technology |
Advanced Telesensors, Inc.
Advanced Telesensors, Inc. Packaged SoftwareTechnology Services Advanced Telesensors, Inc. develops heart rate sensor which auto-captures heart and respiratory rates at a distance. It offers Sleep Tyte, a video monitoring system for parents to view their baby’s physical condition via smartphones. The company was founded by Paolo Focardi in 2009 and is headquartered in Pasadena, CA. | Technology Services |
